Back to Dividend Stocks
Becton, Dickinson and Company (BDX) logo

Becton, Dickinson and Company

Dividend AristocratS&P 500
BDX|Healthcare|Medical Instruments & Supplies|$149.43|P/E 26.1|MCap 41.2B|NYSE

Last update: May 9, 2026 at 09:32

Dividend Safety Rating

67/ 100Safe

BDX's dividend appears safe and well-supported. Strengths include a 45.3% fcf payout ratio & 32.5% cfo payout ratio. Areas of concern: 0.9x current ratio & 6.7% return on equity. As a Dividend Aristocrat with 25+ consecutive years of increases, BDX has a proven commitment to shareholders.

Based on 15 of 15 metrics

Strengths

  • Dividend Streak: Aristocrat (25+ yrs)Long, uninterrupted dividend track record.
  • Dividend Cut: NoneNo dividend cut in recent history.
  • Earnings Stability: GrowingEarnings have been stable and supportive of the dividend.

Risks

  • Current Ratio: 0.9xLimited short-term liquidity to meet obligations.
  • Return on Equity: 6.7%Return on equity is below industry norms.

Payout & Coverage

Safe
Earnings Payout Ratio
73.0%Caution
FCF Payout Ratio
45.3%Safe
CFO Payout Ratio
32.5%Safe
Interest Coverage
4.1xCaution

Balance Sheet

Caution
Net Debt / Total Assets
33.5%Caution
Current Ratio
0.9xWarning
Debt-to-Equity
71.6Safe

Profitability

Caution
Return on Equity
6.7%Warning
Operating Margin
13.3%Caution
Gross Margin
45.9%Safe
Profit Margin Stability
ModerateCaution

Dividend Track Record

Very Safe
Dividend Streak
Aristocrat (25+ yrs)Very Safe
Dividend Cut
NoneVery Safe
5-Year Dividend CAGR
6.0%Safe
Earnings Stability
GrowingVery Safe

About Becton, Dickinson and Company

Becton, Dickinson and Company is a global medical technology company that develops, manufactures, and sells a broad portfolio of medical supplies, devices, laboratory equipment, and diagnostic products. It serves healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical companies, and the general public worldwide. Key segments include BD Medical, offering peripheral IV and advanced catheters, vascular access technologies, infusion therapy systems, prefillable drug delivery, and sharps disposal; BD Life Sciences, providing specimen collection, blood culturing, molecular testing, flow cytometry, and diagnostic reagents; and BD Interventional, featuring hernia repair, surgical infection prevention, peripheral intervention, urology, and critical care products. Following its spinoff, revenue derives primarily from BD Medical Essentials, Interventional, Connected Care, and Biopharma segments, with significant international operations. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, Becton, Dickinson and Company plays a vital role in advancing medical discovery, diagnostics, and care delivery across the healthcare sector.

Dividend Overview

Dividend Yield

2.35%

Annual Dividend

$3.51

Frequency

Quarterly

Payout Ratio

72.95%

FCF Payout Ratio

45.34%

Stock Price

$149.43

52-Week Range

$127.59 $187.35

Dividend History (2016–2025)

BDX annual dividend per share and yield history

Earnings & Profitability

BDX earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

June 9, 2026

Next Payment Date

June 30, 2026

Dividend Growth

3-Year Dividend CAGR

6.02%

5-Year Dividend CAGR

5.96%

10-Year Dividend CAGR

5.68%

3-Year Total Growth

19.18%

5-Year Total Growth

33.57%

10-Year Total Growth

73.75%

Dividend Aristocrat (25+ yrs)

This company has increased its dividend for 25+ consecutive years.

Income Calculator

BDX Dividend Calculator

Total Investment

$14,943.00

Annual Income

$351.07

Quarterly Income

$87.77

Monthly Income

$29.26

Similar Dividend Stocks

StockYield5Y CAGRPrice
Becton, Dickinson and Company (BDX) logo
BDX
2.35%5.96%$149.43
Agilent Technologies Inc. (A) logo
A
0.87%6.62%$115.62
Cardinal Health Inc. (CAH) logo
CAH
1.11%0.96%$183.65
Edwards Lifesciences Corporation (EW) logo
EW
0.00%N/A$79.96
IDEXX Laboratories, Inc. (IDXX) logo
IDXX
0.00%N/A$560.11
IQVIA Holdings Inc. (IQV) logo
IQV
0.00%N/A$178.71
ResMed Inc. (RMD) logo
RMD
1.13%7.70%$206.76

Frequently Asked Questions

What is BDX's current dividend yield?
Becton, Dickinson and Company (BDX) currently has a dividend yield of 2.35%, based on a stock price of $149.43 and an annual dividend of $3.51.
When is BDX's next dividend payment date?
BDX's next ex-dividend date is 2026-06-09 and the next payment date is 2026-06-30. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does BDX pay in dividends per year?
Becton, Dickinson and Company paid $4.17 per share in annual dividends in 2025. The dividends are paid quarterly.
Has BDX been increasing its dividend?
Yes, Becton, Dickinson and Company is a Dividend Aristocrat (25+ yrs). Its dividend has grown at a 5-year CAGR of 5.96%, a 3-year CAGR of 6.02% and a 10-year CAGR of 5.68%.
Is BDX's dividend safe?
Becton, Dickinson and Company has a payout ratio of 72.95%. Its free cash flow payout ratio is 45.34%. The payout ratio is moderate. Monitor earnings to ensure sustainability.
How is BDX's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates Becton, Dickinson and Company's dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track BDX Dividends with OnlyDividends

What will BDX actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.